Santarelli
et al reported two results: (1) fluoxetine induces hippocampal neurogenesis and
reduces latency to feed in the NSF test via 5-HT1A receptors and (2) hippocampal
irradiation halts neurogenesis in the subgranular zone (SGZ), causing
fluoxetine to have no anti-depressant effect. Santarelli’s experiments were
elegantly done, but I’m not convinced that neurogenesis is the cause of the
effects seen from fluoxetine. Using 5HT1A-R knockout mice demonstrated that chronic
treatment with fluoxetine is sufficient to reduce latency to feed in WT mice;
however, the same effect is seen using 8-OH-DPAT, a 5HT1A-selective agonist.
How do we know if the fluoxetine-induced neurogenesis and its anti-depressant
effects are independent of each other or not? If fluoxetine and 8-OH-DPAT have
the same effects, couldn’t the reduced latency to feed be caused solely by
agonists binding 5HT1A receptors? Neurogenesis occurs, but there’s no timeline
of when it happened relative to the decreased latency to feed occurred.
Similar to
their first results, Santarelli et al show data that the number of BrdU+ cells
decrease following hippocampal irradiation, but they do not say if 5HT1A
receptors are affected by the radiation, nor do they specify which strain of
mice they irradiate. Therefore, isn’t it possible that the radiation is simply damaging
5HT1A receptors, which then prevents fluoxetine from working? If a method to quantify
the amount of 5HT1A receptors exists, I would have liked to see these data in
Santarelli’s experiment.
Bessa et al
reported data mainly in opposition to Santarelli. Namely, Bessa reported that
neurogenesis was important for the behavioral effects seen from using
anti-depressants, but not for the mechanism of the drug itself. Using MAM as a
method of arresting neurogenesis is, in my opinion, a more reliable method than
irradiation. Bessa’s data also imply that restoration of synaptic contacts was
the possible mechanism by which anti-depressants were working. This raises the
question: Before the administration of anti-depressants, could synaptic
remodeling occur outside of the hippocampus and PFC to mediate depressive-like
behaviors? Other pathways in the brain that are involved in stress and fear may
be strengthened and weakened under stressful conditions or with anti-depressant
treatments.
The
Santarelli and Bessa paper provide a good overview of the possible effects that
symptoms of depression and anti-depressants may have on the brain. However, there
is no definitive mechanism of depression or its treatment that has been
identified, thus indicating the need for further research. New techniques such
as DREADDS, optogenetics, or genetic knockouts of Ncam1 or Syn1 genes could
provide more specific results about the function of the hippocampus and PFC in
depression.
Comments
Post a Comment